Latest News & Updates
Breaking News
1 hour ago
Simantini Singh Deo
Other trending news you may like to read
Vistagen Appoints Neuroscience Drug Development Veteran Dr. Douglas J. Williamson To Board Of Directors
Vistagen appoints Dr. Douglas J. Williamson, veteran neuroscience drug developer, to its Board of Directors to support its pherine pipeline.
Simantini Singh Deo
Seosaph Introduces PortiVix, Expanding the Future of Pharma Project & Portfolio Management
SEOPRO evolved into PortiVix under VirtuNx, Seosaph's newly launched enterprise product organization.
Team Pharma Now
Replimune Group Wins FDA Advisory Committee Backing For RP1 Melanoma Therapy Ahead Of August 2 Decision
Replimune Group wins a 10-3 FDA advisory committee vote backing its RP1 melanoma therapy, ahead of the agency's August 2, 2026 decision date.
Simantini Singh Deo
Abivax Aligns with FDA on NDA Strategy For Obefazimod, Remains On Track For 2026 Submission
Abivax aligns with the FDA on its NDA submission strategy for obefazimod, remaining on track for a 2026 filing to treat ulcerative colitis.
Simantini Singh Deo
